SCHEDULE: Nantahala Capital Discloses 9.99% Stake in Curis, Inc.

Nantahala Capital Management, LLC and its principals have reported a 9.99% beneficial ownership stake in Curis, Inc. common stock.

Summary

• Nantahala Capital Management, LLC, along with principals Wilmot B. Harkey and Daniel Mack, filed a Schedule 13G reporting beneficial ownership of 4,215,165 shares of Curis, Inc. common stock.
• The reported stake represents 9.99% of the company's outstanding shares, based on 39,978,693 shares outstanding as of March 24, 2026.
• The holdings include 2,215,165 shares that are issuable upon the exercise of warrants within sixty days.
• The reporting persons maintain shared voting and dispositive power over the entire position.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive development, as it reflects stable institutional backing, though it is a standard regulatory disclosure rather than a fundamental business update.

Positives

• Institutional investment firm demonstrates significant confidence in the company by maintaining a nearly 10% equity position.
• The inclusion of warrant exercises suggests the investors are positioned to increase their equity stake or benefit from potential share price appreciation.

Negatives

• The filing indicates that a significant portion of the position (over 50%) is derived from warrants rather than direct common stock ownership, which may imply a more complex investment structure.

Risks

• The concentration of ownership by a single investment firm could lead to increased stock volatility if the firm decides to divest its position.
• The reliance on warrant exercise for a portion of the beneficial ownership introduces sensitivity to the company's share price performance relative to the warrant strike prices.

Future Outlook

The filing does not provide specific forward-looking guidance regarding the company's operations, but confirms the reporting persons acquired the securities in the ordinary course of business without the intent to change or influence control of the issuer.

Industry Context

StockSavvy.ai notes that institutional filings of this nature are common in the biotechnology sector, where specialized investment firms often take significant positions in small-cap companies to support clinical development or capitalize on potential valuation inflection points.

Comparison to Industry Standards

• A 9.99% stake is a standard threshold for institutional investors to maintain to avoid triggering more stringent 'activist' reporting requirements under SEC rules.
• The use of warrants as part of an institutional holding is a common strategy in biotech financing to provide leverage while managing capital allocation.

Related Party Transactions

• Nantahala Capital Partners Limited Partnership and Blackwell Partners LLC Series A are identified as funds advised by Nantahala that have the right to receive proceeds from the securities.

Stakeholder Impact

• Shareholders may view the presence of a 9.99% institutional holder as a sign of stability and long-term interest in the company's equity.

Next Steps

• The reporting persons will continue to monitor their investment in the ordinary course of business.

Key Dates

Keywords

Curis, Nantahala Capital, Schedule 13G, Institutional Ownership, Biotech, Equity Stake